Clinical Trials

1 210 211 212 213 214 221
Number of results: 4412

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-07-20 GLPG0492

Duchenne muscular dystrophy

1 Galapagos (Belgium) Genetic diseases - Neuromuscular diseases - Rare diseases
2011-07-19 EHT Dx14 breast cancer Exonhit (France) Cancer Oncology
2011-07-19 Actemra® (tocilizumab) rheumatoid arthritis 3 Chugai (Japan) Roche (Switzerland) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-07-19 HIV-neutralizing antibody 2G12 HIV-AIDS 1 Pharma-Planta (EU Sixth Framework Integrated Project that was launched in 2004, involving 30 academic and industrial partners) Infectious diseases
2011-07-18 AIC316 genital herpes 2 AiCuris (Germany) Infectious diseases
2011-07-18 IHD-Amy blood test Alzheimer's disease Innovative Health Diagnostics (France) Neurodegenerative diseases
2011-07-15 EV-077 complications of diabetes 1 Evolva (Switzerland) Metabolic diseases
2011-07-14 SBG Soluble Beta-Glucan neuroblastoma 1-2 Biotec Pharmacon (Norway) Cancer Oncology
2011-07-13 Aviscumine (CY503) refractory metastatic melanoma (stage IV) 2 Cytavis Biopharma (Germany) Cancer Oncology
2011-07-12 sarilumab

rheumatoid arthritis

2b Sanofi (France) Regeneron Pharmaceutical (USA) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-07-12 sarilumab

ankylosing spondylitis

2b Sanofi (France) Regeneron Pharmaceutical (USA) Autoimmune diseases
2011-07-12 GFT505 2a Genfit (France) Metabolic diseases - Cardiovascular diseases
2011-07-11 Lemtrada® (alemtuzumab)

multiple sclerosis

3 Sanofi (France) Genzyme (USA - MA) Autoimmune diseases - Neurodegenerative diseases
2011-07-09 NuQ™ and NuQ-X™ tests prospective study VolitionRX (Singapore) - Rheinische Friedrich-Wilhelms-Universität Bonn (Bonn University - Germany) Cancer - Oncology
2011-07-07 Multaq® (dronedarone) permanent atrial fibrillation 3 Sanofi (France) Cardiovascular diseases
2011-07-07 Zaltrap® (aflibercept)

hormone-refractory metastatic prostate cancer

3 Regeneron Pharmaceutical (USA) Sanofi (France) Cancer - Oncology
2011-07-07 AXL1717 solid tumors 1-2 Axelar (Sweden) Cancer - Oncology
2011-07-05 OPN-305

prevention of Delayed Graft Function (DGF) following renal transplantation

1 Opsona Therapeutics (Ireland) Transplantation - Renal diseases - Kidney diseases
2011-06-30 talactoferrin severe sepsis 2-3 Agennix (Germany) Infectious diseases
2011-06-29 NVA237 (glycopyrronium bromide)

chronic obstructive pulmonary disease (COPD)

3 Novartis (Switzerland) Respiratory diseases